Connect with us

Health

The latest numbers on COVID-19 in Canada for Sunday, Feb. 7, 2021 – Burnaby Now

Published

 on


The latest numbers of confirmed COVID-19 cases in Canada as of 7:30 p.m. ET on Sunday Feb. 7, 2021.

There are 804,260 confirmed cases in Canada.

_ Canada: 804,260 confirmed cases (44,727 active, 738,766 resolved, 20,767 deaths).*The total case count includes 13 confirmed cases among repatriated travellers.

There were 3,203 new cases Sunday. The rate of active cases is 117.69 per 100,000 people. Over the past seven days, there have been a total of 24,407 new cases. The seven-day rolling average of new cases is 3,487.

There were 65 new reported deaths Sunday. Over the past seven days there have been a total of 735 new reported deaths. The seven-day rolling average of new reported deaths is 105. The seven-day rolling average of the death rate is 0.28 per 100,000 people. The overall death rate is 54.64 per 100,000 people. 

There have been zero tests completed.

_ Newfoundland and Labrador: 416 confirmed cases (19 active, 393 resolved, four deaths).

There was one new case Sunday. The rate of active cases is 3.64 per 100,000 people. Over the past seven days, there has been eight new case. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 0.77 per 100,000 people. 

There have been zero tests completed.

_ Prince Edward Island: 113 confirmed cases (three active, 110 resolved, zero deaths).

There were zero new cases Sunday. The rate of active cases is 1.88 per 100,000 people. Over the past seven days, there have been a total of two new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is zero per 100,000 people. 

There have been zero tests completed.

_ Nova Scotia: 1,585 confirmed cases (eight active, 1,512 resolved, 65 deaths).

There was one new case Sunday. The rate of active cases is 0.82 per 100,000 people. Over the past seven days, there has been five new case. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 6.64 per 100,000 people. 

There have been zero tests completed.

_ New Brunswick: 1,344 confirmed cases (204 active, 1,120 resolved, 20 deaths).

There were seven new cases Sunday. The rate of active cases is 26.1 per 100,000 people. Over the past seven days, there have been a total of 88 new cases. The seven-day rolling average of new cases is 13.

There were zero new reported deaths Sunday. Over the past seven days there have been a total of two new reported deaths. The seven-day rolling average of new reported deaths is zero. The seven-day rolling average of the death rate is 0.04 per 100,000 people. The overall death rate is 2.56 per 100,000 people. 

There have been zero tests completed.

_ Quebec: 270,058 confirmed cases (11,915 active, 248,112 resolved, 10,031 deaths).

There were 1,081 new cases Sunday. The rate of active cases is 138.96 per 100,000 people. Over the past seven days, there have been a total of 7,475 new cases. The seven-day rolling average of new cases is 1,068.

There were 32 new reported deaths Sunday. Over the past seven days there have been a total of 237 new reported deaths. The seven-day rolling average of new reported deaths is 34. The seven-day rolling average of the death rate is 0.39 per 100,000 people. The overall death rate is 116.99 per 100,000 people. 

There have been zero tests completed.

_ Ontario: 278,207 confirmed cases (14,799 active, 256,903 resolved, 6,505 deaths).

There were 1,489 new cases Sunday. The rate of active cases is 100.44 per 100,000 people. Over the past seven days, there have been a total of 9,996 new cases. The seven-day rolling average of new cases is 1,428.

There were 22 new reported deaths Sunday. Over the past seven days there have been a total of 317 new reported deaths. The seven-day rolling average of new reported deaths is 45. The seven-day rolling average of the death rate is 0.31 per 100,000 people. The overall death rate is 44.15 per 100,000 people. 

There have been zero tests completed.

_ Manitoba: 30,237 confirmed cases (3,256 active, 26,135 resolved, 846 deaths).

There were 79 new cases Sunday. The rate of active cases is 236.07 per 100,000 people. Over the past seven days, there have been a total of 673 new cases. The seven-day rolling average of new cases is 96.

There were four new reported deaths Sunday. Over the past seven days there have been a total of 17 new reported deaths. The seven-day rolling average of new reported deaths is two. The seven-day rolling average of the death rate is 0.18 per 100,000 people. The overall death rate is 61.34 per 100,000 people. 

There have been zero tests completed.

_ Saskatchewan: 25,403 confirmed cases (2,363 active, 22,701 resolved, 339 deaths).

There were 194 new cases Sunday. The rate of active cases is 200.48 per 100,000 people. Over the past seven days, there have been a total of 1,539 new cases. The seven-day rolling average of new cases is 220.

There were three new reported deaths Sunday. Over the past seven days there have been a total of 35 new reported deaths. The seven-day rolling average of new reported deaths is five. The seven-day rolling average of the death rate is 0.42 per 100,000 people. The overall death rate is 28.76 per 100,000 people. 

There have been zero tests completed.

_ Alberta: 126,767 confirmed cases (6,242 active, 118,816 resolved, 1,709 deaths).

There were 351 new cases Sunday. The rate of active cases is 141.16 per 100,000 people. Over the past seven days, there have been a total of 2,559 new cases. The seven-day rolling average of new cases is 366.

There were four new reported deaths Sunday. Over the past seven days there have been a total of 70 new reported deaths. The seven-day rolling average of new reported deaths is 10. The seven-day rolling average of the death rate is 0.23 per 100,000 people. The overall death rate is 38.65 per 100,000 people. 

There have been zero tests completed.

_ British Columbia: 69,716 confirmed cases (5,903 active, 62,567 resolved, 1,246 deaths).

There were zero new cases Sunday. The rate of active cases is 114.67 per 100,000 people. Over the past seven days, there have been a total of 2,056 new cases. The seven-day rolling average of new cases is 294.

There were zero new reported deaths Sunday. Over the past seven days there have been a total of 57 new reported deaths. The seven-day rolling average of new reported deaths is eight. The seven-day rolling average of the death rate is 0.16 per 100,000 people. The overall death rate is 24.2 per 100,000 people. 

There have been zero tests completed.

_ Yukon: 70 confirmed cases (zero active, 69 resolved, one deaths).

There were zero new cases Sunday. Over the past seven days, there have been a total of zero new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is 2.38 per 100,000 people. 

There have been zero tests completed.

_ Northwest Territories: 32 confirmed cases (one active, 31 resolved, zero deaths).

There were zero new cases Sunday. The rate of active cases is 2.21 per 100,000 people. Over the past seven days, there have been a total of one new cases. The seven-day rolling average of new cases is zero.

There have been no deaths reported over the past week. The overall death rate is zero per 100,000 people. 

There have been zero tests completed.

_ Nunavut: 299 confirmed cases (14 active, 284 resolved, one deaths).

There were zero new cases Sunday. The rate of active cases is 35.58 per 100,000 people. Over the past seven days, there have been a total of five new cases. The seven-day rolling average of new cases is one.

There have been no deaths reported over the past week. The overall death rate is 2.54 per 100,000 people. 

There have been zero tests completed.

This report was automatically generated by The Canadian Press Digital Data Desk and was first published Feb. 7, 2021.

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

A look at COVID-19 vaccinations in Canada on Friday, Feb. 26, 2021 – Thompson Citizen

Published

 on


The latest numbers on COVID-19 vaccinations in Canada as of 10:30 p.m. ET on Friday, Feb. 26, 2021.

In Canada, the provinces are reporting 67,201 new vaccinations administered for a total of 1,774,599 doses given. The provinces have administered doses at a rate of 4,682.409 per 100,000.

article continues below

There were 398,071 new vaccines delivered to the provinces and territories for a total of 2,441,670 doses delivered so far. The provinces and territories have used 72.68 per cent of their available vaccine supply.

Please note that Newfoundland, P.E.I., Nova Scotia, New Brunswick and the territories typically do not report on a daily basis.

Newfoundland is reporting 3,827 new vaccinations administered over the past seven days for a total of 20,285 doses given. The province has administered doses at a rate of 38.739 per 1,000. There were 7,020 new vaccines delivered to Newfoundland for a total of 33,820 doses delivered so far. The province has received enough of the vaccine to give 6.5 per cent of its population a single dose. The province has used 59.98 per cent of its available vaccine supply.

P.E.I. is reporting 1,485 new vaccinations administered over the past seven days for a total of 12,176 doses given. The province has administered doses at a rate of 76.758 per 1,000. There were 1,670 new vaccines delivered to P.E.I. for a total of 14,715 doses delivered so far. The province has received enough of the vaccine to give 9.3 per cent of its population a single dose. The province has used 82.75 per cent of its available vaccine supply.

Nova Scotia is reporting 6,987 new vaccinations administered over the past seven days for a total of 32,019 doses given. The province has administered doses at a rate of 32.81 per 1,000. There were 14,700 new vaccines delivered to Nova Scotia for a total of 61,980 doses delivered so far. The province has received enough of the vaccine to give 6.4 per cent of its population a single dose. The province has used 51.66 per cent of its available vaccine supply.

New Brunswick is reporting 5,135 new vaccinations administered over the past seven days for a total of 26,317 doses given. The province has administered doses at a rate of 33.738 per 1,000. There were 11,760 new vaccines delivered to New Brunswick for a total of 46,775 doses delivered so far. The province has received enough of the vaccine to give 6.0 per cent of its population a single dose. The province has used 56.26 per cent of its available vaccine supply.

Quebec is reporting 13,464 new vaccinations administered for a total of 400,540 doses given. The province has administered doses at a rate of 46.81 per 1,000. There were 28,500 new vaccines delivered to Quebec for a total of 537,825 doses delivered so far. The province has received enough of the vaccine to give 6.3 per cent of its population a single dose. The province has used 74.47 per cent of its available vaccine supply.

Ontario is reporting 21,805 new vaccinations administered for a total of 643,765 doses given. The province has administered doses at a rate of 43.826 per 1,000. There were 220,030 new vaccines delivered to Ontario for a total of 903,285 doses delivered so far. The province has received enough of the vaccine to give 6.1 per cent of its population a single dose. The province has used 71.27 per cent of its available vaccine supply.

Manitoba is reporting 2,409 new vaccinations administered for a total of 71,469 doses given. The province has administered doses at a rate of 51.902 per 1,000. There were 6,100 new vaccines delivered to Manitoba for a total of 108,460 doses delivered so far. The province has received enough of the vaccine to give 7.9 per cent of its population a single dose. The province has used 65.89 per cent of its available vaccine supply.

Saskatchewan is reporting 4,015 new vaccinations administered for a total of 69,451 doses given. The province has administered doses at a rate of 58.899 per 1,000. There were 15,210 new vaccines delivered to Saskatchewan for a total of 74,605 doses delivered so far. The province has received enough of the vaccine to give 6.3 per cent of its population a single dose. The province has used 93.09 per cent of its available vaccine supply.

Alberta is reporting 11,728 new vaccinations administered for a total of 207,300 doses given. The province has administered doses at a rate of 47.092 per 1,000. There were 69,090 new vaccines delivered to Alberta for a total of 274,965 doses delivered so far. The province has received enough of the vaccine to give 6.2 per cent of its population a single dose. The province has used 75.39 per cent of its available vaccine supply.

British Columbia is reporting 12,490 new vaccinations administered for a total of 252,373 doses given. The province has administered doses at a rate of 49.18 per 1,000. There were 15,491 new vaccines delivered to British Columbia for a total of 323,340 doses delivered so far. The province has received enough of the vaccine to give 6.3 per cent of its population a single dose. The province has used 78.05 per cent of its available vaccine supply.

Yukon is reporting zero new vaccinations administered for a total of 15,174 doses given. The territory has administered doses at a rate of 363.615 per 1,000. There were zero new vaccines delivered to Yukon for a total of 18,900 doses delivered so far. The territory has received enough of the vaccine to give 45 per cent of its population a single dose. The territory has used 80.29 per cent of its available vaccine supply.

The Northwest Territories are reporting zero new vaccinations administered for a total of 16,454 doses given. The territory has administered doses at a rate of 364.68 per 1,000. There were zero new vaccines delivered to the Northwest Territories for a total of 19,100 doses delivered so far. The territory has received enough of the vaccine to give 42 per cent of its population a single dose. The territory has used 86.15 per cent of its available vaccine supply.

Nunavut is reporting 19 new vaccinations administered for a total of 7,276 doses given. The territory has administered doses at a rate of 187.884 per 1,000. There were 8,500 new vaccines delivered to Nunavut for a total of 23,900 doses delivered so far. The territory has received enough of the vaccine to give 62 per cent of its population a single dose. The territory has used 30.44 per cent of its available vaccine supply.

*Notes on data: The figures are compiled by the COVID-19 Open Data Working Group based on the latest publicly available data and are subject to change. Note that some provinces report weekly, while others report same-day or figures from the previous day. Vaccine doses administered is not equivalent to the number of people inoculated as the approved vaccines require two doses per person. The vaccines are currently not being administered to children under 18 and those with certain health conditions. In some cases the number of doses administered may appear to exceed the number of doses distributed as some provinces have been drawing extra doses per vial.

This report was automatically generated by The Canadian Press Digital Data Desk and was first published Feb. 26, 2021.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada approves AstraZeneca’s COVID-19 shot, 500,000 doses to arrive next week

Published

 on

By Julie Gordon and Allison Martell

OTTAWA (Reuters) – Canada on Friday approved AstraZeneca’s COVID-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week.

The vaccine is the third to be approved by Health Canada following the December approval of vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc.

“With Pfizer, Moderna, and now AstraZeneca, Canada will get more than 6.5 million doses before the end of March,” Prime Minister Justin Trudeau told reporters. “And there will be tens of millions more doses to come between April and June.”

Canada has ordered 20 million doses of the vaccine from AstraZeneca, and is due to receive 1.9 million through COVAX – the international initiative set up to provide equitable access to vaccines – in the first half of the year.

On Friday, Canada said it had secured an additional 2 million doses through its agreement with Verity Pharmaceuticals Canada Inc and the Serum Institute of India.

The initial 500,000 doses would arrive in coming weeks and be ready to distribute to provinces and territories, Procurement Canada said. The remaining 1.5 million doses would arrive by mid-May.

Verity Pharmaceuticals Chief Executive Howard Glase said 500,000 doses would arrive in Canada on Wednesday.

While Canada has ordered more COVID-19 vaccine doses per capita any other country, its initial roll-out has been slow in part because of temporary disruptions in deliveries from manufacturers. None of the approved vaccines are made in Canada.

The added doses from the Serum Institute of India are meant to accelerate the inoculation drive and could safeguard against future delays from other manufacturers.

AstraZeneca has told the European Union it expects to deliver less than half the COVID-19 doses it was contracted to supply in the second quarter, an EU official said.

Canada has reported 858,217 coronavirus infections and 21,865 deaths since the start of the pandemic about a year ago.

Health Canada approved the AstraZeneca vaccine for all adults under Health Canada‘s accelerated approval system, saying its efficacy in those over age 65 was supported in part by evidence gathered outside of clinical trials. It said the efficacy of the vaccine was 62.1%.

The United States has not yet approved the AstraZeneca vaccine, but the European Union has. Germany is only using the product on people under 65.

Trudeau has said repeatedly that every willing resident will be able to get inoculated by the end of September.

“But of course we have seen there can be bumps in the road – things can happen on the manufacturing side,” said Health Minister Patty Hajdu on Friday.

The timing of Health Canada‘s decisions on two other vaccines, produced by Johnson & Johnson and Novavax Inc, is likely to be “in line with the other major regulators,” said Supriya Sharma, the chief medical adviser at the regulator.

The J&J review is pretty much complete, with some manufacturing information expected on Friday, Sharma said. The U.S. Food and Drug Administration’s expert advisory panel is expected to recommend authorization for J&J’s one-shot vaccine on Friday.

 

(Reporting by Allison Martell and Julie Gordon, additional reporting by Steve Scherer and David Ljunggren; Editing by Jonathan Oatis and Grant McCool)

Continue Reading

Health

Health Canada approves AstraZeneca's COVID-19 vaccine – Kamloops This Week

Published

 on


OTTAWA — Health Canada decided Friday to authorize the AstraZeneca vaccine and the first half million doses of it will be shipped to Canada next week.

The regulatory team reviewing COVID-19 vaccines said the one by AstraZeneca is both safe and effective and can be used immediately on people over the age of 18.

article continues below

“This is very encouraging news,” said Prime Minister Justin Trudeau. “It means more people vaccinated, and sooner.”

AstraZeneca joins the Pfizer-BioNTech and Moderna vaccines on the list of those authorized in Canada. Clinical trials showed it to be less effective at preventing infection than the first two, but it is still keeping people from getting very sick or dying, said Dr. Supriya Sharma, the chief medical adviser at Health Canada.

Pfizer and Moderna both reported being 95 per cent effective at preventing COVID-19 infections in patients who received the vaccine, compared to those who received a placebo. AstraZeneca was 62 per cent effective.

But Sharma said the “key numbers” to examine when looking at all the vaccines Canada has approved or is reviewing is whether they prevented serious illness and death.

“If you look across all the clinical trials of the tens of thousands of people that were involved, the number of cases of people that died from COVID-19, that got vaccine was zero,” she said. “The number of people that were hospitalized because their COVID-19 disease was so severe was zero. The number of people that died because of an adverse event or an effect of the vaccine was zero.”

It’s not entirely clear yet how provinces and territories will incorporate the AstraZeneca vaccine into their vaccination programs, but because it is can be shipped and stored in refrigerators instead of freezers, it is a more flexible option.

Sharma said AstraZeneca’s review process included not only the clinical trial data submitted by the company but also evidence of how the vaccine has been working in the real world. Millions of people in more than 50 countries have now received the vaccine since it was first approved at the end of December.

Canada anticipated getting enough vaccine from Pfizer-BioNTech and Moderna to vaccinate three million people by the end of March, 14.5 million people by the end of June, and all 38 million Canadians by the end of September.

The addition of AstraZeneca should quicken that pace.

Canada is getting 24 million doses by September, and as many as one million by the end of March. That includes 20 million directly from AstraZeneca, and made in the United States, between April and September. Another 1.9 million doses made in South Korea and delivered via the vaccine sharing initiative known as COVAX are to come by the end of June, and the first 500,000 of those could be delivered in the next month.

Procurement Minister Anita Anand also said a deal to get another two million doses from the Serum Institute of India was finalized Thursday. Verity Pharmaceuticals, which is facilitating the Serum Institute’s application in Canada, said Friday the first 500,000 will come next week, followed by one million in mid-April, and the rest in early May.

AstraZeneca vaccines are to be given in two doses between four and 12 weeks apart. Sharma said there is some indication that waiting longer provokes a better response, but that data is not yet complete.

There have been some concerns raised about the AstraZeneca vaccine in recent weeks, including how well it works against variants and whether there is enough data to show it works on older individuals.

Several European countries, including Germany and France, limited AstraZeneca to people under the age of 65. Sharma said there were a limited number of people over 65 involved in the clinical trials, but that data, coupled with the real-world experience in the United Kingdom, shows strong evidence seniors are protected.

“When we do the authorization, the question is, for somebody 65 years of age and older, with the benefits of getting the vaccine versus not getting the vaccine, would the benefits outweigh the risk,” she said. “And the answer to that was yes based on all the information that we have.

The National Advisory Committee on Immunization will issue guidance for how best to use the vaccine in the next few days, said Sharma. Provinces can then determine how they will incorporate it into their planning.

Canada’s vaccine program is shifting into a higher gear after a month-long slowdown in deliveries due to production issues for Pfizer and Moderna. More than 300,000 people were vaccinated in the last week, almost one-fifth of the total doses injected since the first vaccinations began Dec. 14.

As of Friday afternoon about 700,000 people have received one dose and more than 500,000 are now fully vaccinated with two doses.

The AstraZeneca vaccine works differently than the other two already in use in Canada.

Both Pfizer-BioNTech and Moderna use messenger RNA technology, using RNA encoded with the piece of the SARS-CoV-2 virus known as the spike protein. The mRNA trains the body to fight off a COVID-19 infection.

AstraZeneca is a viral vector vaccine, which takes a cold virus, modifies it so it can’t reproduce itself, and adds the SARS-CoV-2 spike protein. When injected, it too provokes the body to develop infection-fighting antibodies and cells to fight the virus.

The U.S. Food and Drug Administration was meeting Friday to decide whether to authorize the vaccine from Johnson and Johnson, and Sharma said Health Canada was expecting some final data on manufacturing from that company Friday.

An approval for it could soon follow.

A fifth vaccine from Novavax expects to report clinical trial data in April, paving the way for Health Canada to make a decision about it this spring.

Those two vaccines would add another 62 million doses to Canada’s supply.

This report by The Canadian Press was first published Feb. 26, 2021.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending